TVTX
Travere Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.77B
P/E Ratio
—
EPS
$-0.57
Beta
0.87
52W High
$43.31
52W Low
$13.88
50-Day MA
$31.23
200-Day MA
$28.27
Dividend Yield
—
Profit Margin
-5.21%
Forward P/E
54.64
PEG Ratio
—
About Travere Therapeutics Inc
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $490.73M |
| Gross Profit (TTM) | $274.38M |
| EBITDA | $-2.08M |
| Operating Margin | -25.00% |
| Return on Equity | -57.80% |
| Return on Assets | -6.55% |
| Revenue/Share (TTM) | $5.50 |
| Book Value | $1.26 |
| Price-to-Book | 32.58 |
| Price-to-Sales (TTM) | 7.68 |
| EV/Revenue | 7.64 |
| EV/EBITDA | 168.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 73.40% |
| Shares Outstanding | $92.37M |
| Float | $91.24M |
| % Insiders | 0.76% |
| % Institutions | 115.25% |
Historical Volatility
HV 10-Day
165.81%
HV 20-Day
126.07%
HV 30-Day
106.21%
HV 60-Day
85.60%
HV Rank
96.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($49.57 target)
1
Strong Buy12
Buy2
HoldData last updated: 4/28/2026